CAR T-cell therapies are individualized treatments approved for multiple hematologic malignancies, with improved management of adverse effects over time. Access to CAR T-cell therapies is limited by ...
A cell-mimicking nanosensor uses lubricin and SERS to detect drugs in whole blood in real time, resisting fouling for over 10 hours of continuous monitoring. (Nanowerk News) A team led by La Trobe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results